BARTEČEK, Richard, Tomáš KAŠPÁREK a Eva ČEŠKOVÁ. Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia. Central European Journal of Medicine. Warsaw (Poland): Versita, 2011, roč. 6, č. 5, s. 662-664. ISSN 1895-1058. Dostupné z: https://dx.doi.org/10.2478/s11536-011-0055-8.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia
Název česky Zmínění nežádoucích účinků antipsychotické medikace u pacientů s první epizodou schizofrenie
Autoři BARTEČEK, Richard (203 Česká republika, garant, domácí), Tomáš KAŠPÁREK (203 Česká republika, domácí) a Eva ČEŠKOVÁ (203 Česká republika, domácí).
Vydání Central European Journal of Medicine, Warsaw (Poland), Versita, 2011, 1895-1058.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30000 3. Medical and Health Sciences
Stát vydavatele Polsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 0.312
Kód RIV RIV/00216224:14110/11:00053792
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2478/s11536-011-0055-8
UT WoS 000293708800022
Klíčová slova česky schizofrenie; antipsychotika; zmírnění nežádoucích účinků
Klíčová slova anglicky schizophrenia; antipsychotics; withdrawal related adverse effects
Příznaky Mezinárodní význam
Změnil Změnil: Mgr. Michal Petr, učo 65024. Změněno: 2. 2. 2012 16:12.
Anotace
Withdrawal-emergent adverse effects of antipsychotics are an infrequently identified condition which can appear during antipsychotic dose reduction and medication change. In this paper, we present the case of severe extrapyramidal symptoms after a dose reduction of risperidone is presented. A patient, 23 years of age, was admitted to a health care facility due to an unexpected change in his behavior, with paranoid delusions, incoherent thinking, and significant anxiety. An initial risperidone treatment was soon changed to zuclopenhixol. Subsequently, severe extrapyramidal symptoms appeared, after which the medication was switched back to resperidone. Following this treatment, the patient left the health care facility and stopped the medication of his own volition. Psychotic symptoms and massive extrapyramidal symptoms again occurred. These symptoms subsided only slowly during a subsequent treatment with olanzapine. The development of adverse neurological effects together with a worsening of productive psychotic symptomatology may be explained by withdrawal of antipsychotic medication. These symptoms are often attributed to new medications, which are prematurely discontinued after the appearance of an adverse effect, but which are potentially beneficial to a patient, provided that enough time for a spontaneous subsidence of withdrawal-emergent effects is given. Any change in antipsychotic treatment should be carefully considered and thoroughly planned.
VytisknoutZobrazeno: 17. 7. 2024 18:25